The global market of radiotherapy experiencing rapid growth due to the increasing rate of cancer all over the world. Thus, according to the statistics of the World Health Organization, cancer is the second biggest killer globally. Furthermore, in 2023, the U.S. National Cancer Institute reported a 7% rise in federal funding for cancer research and treatments. More specifically, over USD 8.4 billion has been allocated to support radiotherapy advancement. Moreover, in Europe, the European Commission has increased the Cancer Mission budget up to Euro 1.2 billion in the framework of the “Beating Cancer Plan”.